Skip to main content
. Author manuscript; available in PMC: 2018 Apr 12.
Published in final edited form as: Catheter Cardiovasc Interv. 2015 Apr 24;86(2):E38–E48. doi: 10.1002/ccd.25566

Fig. 3.

Fig. 3

Fig. 3

(A) CFR revealed significant increases in the single bolus and the divided dose groups than the placebo group (*P<0.01 and **P<0.05). (B) The decreases in the perfusion defect area (%) during the follow-up correlated with the increases in CFR.